CTI clinical trials making cancer more treatable Making Cancer More Treatable
Cancer research products for clinical trials / Investigational Products / Clinical trials for lung cancer in women
CTI clinical trials for lung cancer in women
XYOTAX
Pixantrone cancer research drug for non-Hodgkin's lymphoma
Brostallicin cancer treatment for sarcoma
CT-2106
Clinical Studies
Clinical trials in lung cancer
Clinical trials for ovarian cancer
Clinical trial in soft tissue sarcoma
 

Lung Cancer Clinical Trial - PGT307

PGT307 lung cancer trials are enrolling in these locations:

Would you like more information about a PGT307 lung cancer clinical trial site?

Sites are in the process of being opened for this trial, and we'll add new locations to this list as they are established.

Please email Medical Information Inquiries, or call 1-800-715-0944 (U.S. only) for more information about an existing site or to be placed on a notification list when a site is opened in your area.

Clinical trials for lung cancer in the United States Back to lung cancer trials

Posted May 23, 2008

Copyright © 2004-2008 Cell Therapeutics, Inc., Seattle, WA, USA. All rights reserved. "Making cancer more treatable" is a registered mark of CTI.